Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13.
about
IL-4 and IL-13 signaling in allergic airway diseaseExtract of Nippostrongylus brasiliensis stimulates polyclonal type-2 immunoglobulin response by inducing De novo class switchThe macroimportance of the pulmonary immune microenvironment.Induction and regulation of the IgE response.Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis.An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.Importance of cytokines in murine allergic airway disease and human asthma.The high-affinity IgE receptor (FcepsilonRI): a critical regulator of airway smooth muscle cells?Biochanin a, a phytoestrogenic isoflavone with selective inhibition of phosphodiesterase 4, suppresses ovalbumin-induced airway hyperresponsiveness.S-Petasin, the Main Sesquiterpene of Petasites formosanus, Inhibits Phosphodiesterase Activity and Suppresses Ovalbumin-Induced Airway Hyperresponsiveness.Contribution of IL-13 to early exocrinopathy in Id3-/- mice.Hesperetin-7,3'-O-dimethylether selectively inhibits phosphodiesterase 4 and effectively suppresses ovalbumin-induced airway hyperresponsiveness with a high therapeutic ratio.Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma.Hesperetin, a Selective Phosphodiesterase 4 Inhibitor, Effectively Suppresses Ovalbumin-Induced Airway Hyperresponsiveness without Influencing Xylazine/Ketamine-Induced AnesthesiaSuppressor of cytokine signalling 1 (SOCS1) is a physiological regulator of the asthma responseHesperidin-3'-o-methylether is more potent than hesperidin in phosphodiesterase inhibition and suppression of ovalbumin-induced airway hyperresponsiveness.Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2.Interleukin 13 and the evolution of asthma therapy.T Cell-Associated Cytokines in the Pathogenesis of Sjögren's SyndromeIL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis.Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain.Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage.Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.Treatment of experimental asthma by decoy-mediated local inhibition of activator protein-1.IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in miceOverlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling.IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury.Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells.Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production.Interleukin-9 upregulates mucus expression in the airways.Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).Targeting IL-4/IL-13 signaling to alleviate oral allergen-induced diarrheaSimultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses.Decoy receptors in the regulation of T helper cell type 2 responses.The IL-13/IL-4Rα axis is involved in tuberculosis-associated pathology.Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling.Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin.Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis.Influence of respiratory syncytial virus infection on cytokine and inflammatory responses in allergic mice.Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy.
P2860
Q26859510-7F437A83-1BA0-468D-B54E-ACC094976AF7Q33597390-DFB9F2B0-415A-4A63-9D7E-CF5030410026Q33719159-20D4C032-75FD-4044-ACFA-34EC3F71D394Q33787602-A94096CD-F50A-4886-8924-FC065A1B9A4CQ33849441-9E564E2D-F9F3-4CBA-8DBC-E48B881B3925Q33853821-0E4FC092-360B-4CDB-997A-290E33AEC3B9Q34003580-FB3FE541-6B34-4347-8A35-7AFDD800449BQ34508253-95A69D97-3B16-409E-89F3-CE0C5C9ED69DQ34706585-0C11F957-19B4-4F2C-BD11-7FF0B5888917Q34981983-93CA287B-519B-408E-93A3-20827DAEDA6AQ35488650-8613A70E-382D-4538-9AD8-D71DC47FA6FAQ35576638-B503125B-839B-4503-AE89-8E67AC7D6BA5Q35627845-EDF4631D-3050-4D53-8B0B-167AC04B9DEFQ35792013-7EC964CC-5887-4FDF-AA67-5367CD06E2D1Q36253193-3EA25440-77EA-44DD-A1E6-042D6866EBB9Q36311412-50FAB7E6-A723-453B-9C4B-8CA25B2AF5DDQ36370592-93959AC8-89F7-41AF-AD66-DF8B007951D3Q36777718-3C32332E-9A07-4EE5-A3CE-8FC710DE579BQ36957148-B5CA1948-0212-404C-BAE0-374B0F342A48Q37071862-C0D157EB-17D7-4007-B972-DCDE0AC1D738Q37217252-AC25A008-A753-4B14-90CF-86BE1B622B0BQ37589643-3AA9F2F2-6ADB-4AE1-856C-08FEDAD4D1A2Q37807414-CD33D637-2A16-4B5C-A1DA-C112D3AC563BQ38324836-AC6193A8-34DB-4CCD-AE1A-0AF88B60E1AFQ38780046-6499022C-A200-4060-92EE-4100CDF5491FQ39735936-A8E5AC65-CD5B-4106-B2B4-B514F994F44BQ40735697-581D356E-3921-4031-A4B6-437B6EC27822Q40809076-ED534A19-8B5E-4850-B5F4-0DCBC3166ED0Q40849898-693AE12E-96B1-4DDE-BAAE-8174C3EC7741Q40876117-A71E356A-F455-4673-9DF1-6F81E44A5817Q42101278-50DEC484-F787-4921-AC44-77721E4EF2ECQ42739851-205A6E55-7EB6-45F0-8410-D144367D5151Q42944667-79C3A584-4D9A-4D22-88E1-F4E4BD7EE02EQ42944812-A12F1635-159D-4B47-9A14-4719DD5A247FQ43082287-192F06D0-9164-4D39-9F6B-ADF005CB9AD0Q43183078-07DE9893-D422-4B61-A5D3-4FFFFC87240FQ43789225-EB613F93-9680-4D68-AEAF-2B8DC8CC4C57Q44491491-AE6AD684-8E10-4ED8-BDB7-53C933DB7620Q45732995-9EA83353-E406-463A-A6AF-133EFF4A061EQ47346696-E0B79FE3-BE46-4343-9144-3EECBB1B97EC
P2860
Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Interleukin (IL)-4-independent ...... nsgenic mice expressing IL-13.
@ast
Interleukin (IL)-4-independent ...... nsgenic mice expressing IL-13.
@en
type
label
Interleukin (IL)-4-independent ...... nsgenic mice expressing IL-13.
@ast
Interleukin (IL)-4-independent ...... nsgenic mice expressing IL-13.
@en
prefLabel
Interleukin (IL)-4-independent ...... nsgenic mice expressing IL-13.
@ast
Interleukin (IL)-4-independent ...... nsgenic mice expressing IL-13.
@en
P2093
P2860
P356
P1476
Interleukin (IL)-4-independent ...... nsgenic mice expressing IL-13.
@en
P2093
P2860
P304
P356
10.1084/JEM.188.2.399
P407
P577
1998-07-01T00:00:00Z